The thymus, May 5 -- clinical translation.

What was once confined to laboratory models and imaging correlations is now entering early human testing, where researchers are attempting to determine whether immune aging can be actively reversed rather than merely measured.

From biological indicator to clinical intervention

Large-scale imaging studies and immunological datasets have already established the thymus as a strong predictor of immune resilience. AI-assisted CT scan analysis has shown that thymic structure correlates with cancer outcomes, inflammatory burden, and overall survival across diverse patient populations.

The current phase of work extends that foundation into intervention research, where scientists are testing whether t...